[Registrazione]  [Modifica profilo]  [Modifica Preferenze]  [Cerca]
[Messaggi privati]  [Lista degli utenti iscritti]  [FAQ]  [Entra]
salutemed.it Forum Index » » CFS Stanchezza cronica » » nueva investigación publicada
Vai alla pagina ( Pagina precedente 1 | 2 )
Autore nueva investigación publicada
Alfred


Registrato: Dec 09, 2003
Messaggi: 30
Località: reus (Tarragona) Espa?a
Inviato: 2005-01-25 10:21   
Estimada Maria Luisa,

Cuando llegué a la conclusion en mi inestigación que esta combinación de iones podía ayudarme, lo primero que hice fué buscar por todo el mundo los productos que estuvieran formados por estas cantidades o proporciones de estos mismos elementos.

Al no encontrar nada en todo el mundo con la misma composición en proporciones exactas, tuve que mezclarlo yo mismo.

Mi máxima sorpresa fue el gran interes que tuvieron algunos laboratorios farmaceuticos por comprarme la patente (que yo no tenia). En ese momento hice la patente mundial y mi otra gran sorpresa fue que no existia ninguna patente en todo el mundo que guardara estas proporciones entre los 4 elementos.

Cuando vino un laboratorio que se comprometió en la investigación, se lo regalé muy contento.

La demostracion definitiva de su eficacia, en estudios a triple ciego se esta llevando a cabo en varios hospitales publicos en Barcelona. Durante este año proximo seguramente ya se publicaran los resultados.
Una investigacion es como tratamiento de la fibromialgia y otra totalmente separada es como tratamiento único para la fatiga crónica
No obstante, es importante decir dos cosas: La primera, es que las proporciones de esta formula son exactamente las mismas que deberia tener una celula muscular sana en los humanos.
La segunda: cuando yo lo mezclaba en mi casa y lo regalaba a quien queria tomarlo, 6 de cada 10 mezclas, debia tirarlas a la basura porque la mezcla no era correcta (aunque las cantidades si que loeran). Esto era debido a la forma de mezclarlo. Al ser a partir de bases con distintas texturas y pesos moleculares, la mezcla no quedaba homogenea. Por esto cuando el laboratorio añadio los controles de fabricación y de calidad, estuve muy contento porque siempre sale bien. Te digo esto, porque si mezcla los mismos elementos quimicos una farmacia, es muy probable que varias veces no salga perfecta la mezcla. Las farmacias normalmente no tienen controles de calidad sobre el producto acabado. Por esto es distinto.
En cuanto tenga los resultados que se publicaran sobre las otras investigaciones, os las pondre en el foro (sean buenos o malos resultados)
La verdad y la sinceridad es lo unico que nos ayuda. No crees?

ALfred
www.alfredblasi.net
TEle. +34 655649669


  Visualizza il profilo di Alfred   Email Alfred   Vai al sito web di Alfred        Modifica/cancella questo Messaggio   Rispondi riportando il messaggio originario
nat49


Registrato: Sep 19, 2004
Messaggi: 778
Inviato: 2005-01-25 10:26   
?Cual hospitales en Barcelona? Los nombres por favor.

  Visualizza il profilo di nat49      Modifica/cancella questo Messaggio   Rispondi riportando il messaggio originario
Alfred


Registrato: Dec 09, 2003
Messaggi: 30
Località: reus (Tarragona) Espa?a
Inviato: 2005-01-25 10:47   
os copio un mensaje que escribió el Dr. JRoses, jefe de investigaciones del laboratorio al que le di la patente. Este mensaje se encuentra en un grupo técnico de USA. Este mensaje está en ingles pero supongo que os será facil traducirlo. Yo conozco de los estudios solamente lo que publica el laboratorio porque estoy totalmente al margen de ellos.:

************************
message: I attach my explanation on the clinical studies in course with Recuperat-ion.
Besides, there is a key factor that explains the motive of the
investigations: to demonstrate scientifically the improvement that
many patients affirm to have with this mineral salts.

J.Roses


Chronic fatigue syndrome and fibromyalgia. Evidence-based health care.

Chronic fatigue syndrome (CFS) is defined as debilitating fatigue with associated symptoms lasting for at least six months. While in the general community, prevalence has been estimated at ~1 in 1000
(Buchwald et al, 1995). Although there are no FDA-approved treatments for CFS, through the management and treatment of symptoms, the prognosis for patients is usually good.

CFS represents a heterogeneous group of patients that manifest symptom complexes with varying degrees of fatigue, limited
exertional reserve and cognitive dysfunction (Shor, 2003). CFS and
fibromyalgia (FM) suffer from various symptoms, including debilitating fatigue, muscle pain, and muscle weakness.

With regard to fatigue and limited exertional reserve, a major criterion for defining CFS is that patients report a greater than 50 % reduction in activity levels relative to their pre-illness state
(Holmes et al, 1988). Exercise capacity was evaluated in a large cohort of female patients with CFS and compared with that of
sedentary controls subjects (De Becker et al, 2000). The VO2max levels of the control group were consistent with various studies in untrained women of approximately the same age describing VO2max levels of 30-36 mL/kg per minute. Female patients with CFS had an average VO2max just below 20 mL/kg per minute, representing significant impairment relative to the controls. This study clearly shows that patients with CFS are limited in their physical capacities, and based on the AMA Guidelines for Impairment Rating, correspond to class 3-4 on the disability scale, indicating moderate to severe impairment.

The exact mechanisms for this are speculative. It may be that loss of muscle protein contributes to the perceived muscle weakness (Preedy et al, 1993). In this regard cytokine abnormalities and dysfunction of the 2-5A Synthetase/Rnase pathway exert a negative control on protein synthesis; both of these anomalies have been demonstrated in CFS. In addition, muscle fibre atrophy and a defect
in muscle energy sources -ATP, PCr and Pi- need to be explored as there is disagreement whether patients with CFS show defect in mitochondrial function. Regardless of the cause and pathogenesis, the symptom complex labelled CFS can and does result in prolonged debilitation. Now, Dr J. Alegre -formely cheef of the CFS Unit- at the Hospital Universitari Vall Hebron in Barcelona (Spain),is carrying out a prospective, randomised, triple-blind
controlled with placebo study. A total of sixty patients (pilot study) who meet the CDC's criteria for CFS were enrolled in the
study, which had been approved by the ethical committee of the Vall d' Hebron Hospital with the accepting of Ministry of Health. The end point is evaluate the efficacy of Recuperation® in the improvement of fatigue, pain and well being (quality of life) of patients with CFS. This study will finish May/June of 2005.

Some experts believe CFS to be closely related to another chronic condition, fibromyalgia (FM). A preliminary follow-up study by the CDC revealed that, for those individuals whose chronic fatigue does
not significantly improve after a 5-year duration, the most prominent symptom changes from fatigue to muscle pain. This muscle pain is the prominent symptom of fibromyalgia.

Fibromyalgia syndrome is common and variable impact, with some patients having a milder and shorter duration of symptoms and other suffering significant and prolonged pain. The exact mechanisms for
this syndrome like CFS, are speculative also. It is thought that the syndrome arises from a disordered neurophysiology that, through links to central control inputs, involves emotions, thoughts, and
cognitions. Some investigators hypothesized that probably it arises from a defect in muscle energy sources -ATP, PCr and Pi- like CFS, or an altered peripheral neuromuscular junction disorder or an
altered muscle fibre contractile machinery disorder mediated by calcium, potassium and sodium ions channels. Now, three
investigators from Barcelona (Dr. C. Alegre, Dr J. Carbonell and Dr.
A. Collado) from Hospital Universitari de la Vall Hebron, Hospital Universitari del Mar, and Hospital Clinic Universitari,
respectively, all in Barcelona (Spain), are carrying out a prospective, randomised, triple-blind controlled with placebo study
with sixty patients who meet the FM diagnostic criteria (pilot study), which had been approved by the ethical committee of these three hospitals, with the accepting of Ministry of Health. The end
point is to evaluate the efficacy of Recuperation® in the improvement of fatigue, pain and well being (quality of life) of patients with FM. This study will finish May/June of 2005.

Joseph Rosés, MD.


Bibliography
Buchwald D et al. Chronic fatigue and the chronic fatigue syndrome:
Prevalence in a Pacific Northwest health care system. Ann Intern Med
1995; 123: 81-88.
De Becker P et al. Exercise capacity in chronic fatigue syndrome.
Arch Intern Med 2000; 160: 3270-3277.
Holmes GP et al. Chronic fatigue syndrome: a working case
definition. Ann Intern Med 1988; 108: 387-389.
Preedy VR et al. Biochemical and muscle studies in patients with
acute post-viral fatigue syndrome. J Clin Pathol 1993; 46: 722-726.
Shor S. Pathogenesis of chronic fatigue syndrome, a multisystem
hypothesis. J Chron Fatigue Syndr 2003; 11 (3): 51-68.


  Visualizza il profilo di Alfred   Email Alfred   Vai al sito web di Alfred        Modifica/cancella questo Messaggio   Rispondi riportando il messaggio originario
nat49


Registrato: Sep 19, 2004
Messaggi: 778
Inviato: 2005-01-25 11:36   
!Gracias! ahora iremos a tomar informaciones

[ Questo messaggio è stato modificato da: nat49 il 2005-01-25 11:57 ]


  Visualizza il profilo di nat49      Modifica/cancella questo Messaggio   Rispondi riportando il messaggio originario
Vai alla pagina ( Pagina precedente 1 | 2 )
  
Blocca questo Argomento Sposta questo Argomento Cancella questo Argomento
Powered by phpBB Versione 1.4.2
Copyright © 2000 - 2001 The phpBB Group

phpBB Created this page in 0.020379 seconds.